| Name of PGD | Publication link and date effective | Advisory documents for Wales (if required) |
|---|---|---|
| BCG vaccine AJV |
01/09/2021 |
|
| Hepatitis A (Havrix® Monodose®, Havrix® Junior Monodose, AVAXIM®, VAQTA® Adult or VAQTA® Paediatric) |
01/11/2021 |
|
| Hepatitis A/B (Twinrix® Adult, Twinrix® Paediatric or Ambirix®) |
01/11/2021 Refer to UKHSA |
|
| Hepatitis A/Typhoid (ViATIM®) |
01/03/2022 Refer to UKHSA |
|
|
Hepatitis B (Engerix B® 10micrograms/0.5ml, Engerix B® 20 micrograms/1ml, HBvaxPRO® 5micrograms/0.5ml, HBvaxPRO® 10micrograms/1ml) |
01/11/2021 Refer to UKHSA |
|
|
Hepatitis B for renal patients (Engerix B® 20micrograms/1ml, Fendrix® 20 micrograms/0.5ml, HBvaxPRO® 40micrograms/1ml) |
01/05/2021 Refer to UKHSA |
|
| Human Papillomavirus (HPV) Vaccine for MSM (Gardasil®) |
01/04/2022 Refer to UKHSA |
|
| MenB risk groups (Bexsero®) |
28/02/2023 Refer to UKHSA |
|
|
MenACWY risk groups |
28/02/2023 Refer to UKHSA |
|
| PCV risk groups (Prevenar®) |
01/03/2022 Refer to UKHSA |
|
| Typhoid Vi vaccine (TYPHIM Vi®) |
01/03/2022 Refer to UKHSA |
|
| Varicella vaccine (Varivax®, Varilrix®) |
05/01/2023 Refer to UKHSA |